Bulletin
Investor Alert

New York Markets After Hours

Epizyme Inc.

NAS: EPZM

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200475462/composite

$

11.94

Change

0.00 0.00%

Volume

Volume 118,664

Sep 25, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200475462/composite

Today's close

$ 11.73

$ 11.94

Change

+0.21 +1.79%

Day low

Day high

$11.61

$12.11

Open
Open: 11.68

52 week low

52 week high

$9.74

$27.82

Open

Market cap

$1.19B

Average volume

933,817

P/E ratio

N/A

Rev. per Employee

$175,000

EPS

-2.08

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/epzm

MarketWatch News on EPZM

  1. Epizyme downgraded to perform from outperform at Oppenheimer

    7:44 a.m. April 1, 2020

    - Tomi Kilgore

  2. Epizyme stock price target raised to $24 from $21 at Wedbush

    9:48 a.m. Dec. 19, 2019

    - Tomi Kilgore

  3. Epizyme's stock jumps on 11-0 vote from FDA adcomm

    3:54 p.m. Dec. 18, 2019

    - Jaimy Lee

  4. Epizyme's stock trades at highest intraday level seen since July 2015

    3:33 p.m. Dec. 18, 2019

    - Tomi Kilgore

  5. Epizyme's stock rockets 24% after resuming trading, after FDA committee votes in favor of Sarcoma treatment

    3:32 p.m. Dec. 18, 2019

    - Tomi Kilgore

  6. Epizyme stock price target raised to $22 from $12 at Morgan Stanley

    11:23 a.m. Dec. 6, 2019

    - Tomi Kilgore

  7. Epizyme upgraded to overweight from equal weight at Morgan Stanley

    11:23 a.m. Dec. 6, 2019

    - Tomi Kilgore

  8. Big Biotech Investors Poured $29 Million Into 2 Battered Companies

    5:00 a.m. Oct. 12, 2018

    - Barron's Online

  9. Epizyme's stock soars after FDA lifts hold on trial enrollments

    7:45 a.m. Sept. 24, 2018

    - Tomi Kilgore

  10. Epizyme downgraded to market perform from outperform at Leerink

    7:02 a.m. July 3, 2018

    - Tomi Kilgore

  11. Epizyme stock price target cut to $16 from $24 at Leerink

    7:02 a.m. July 3, 2018

    - Tomi Kilgore

  12. Epizyme stock price target raised to $25 vs. $20 at Wedbush

    7:59 a.m. May 18, 2018

    - Ciara Linnane

  13. Epizyme started at overweight with $20 stock price target at Morgan Stanley

    10:45 a.m. Jan. 10, 2018

    - Tomi Kilgore

  14. Epizyme downgraded to sector perform from outperform at RBC Capital

    7:57 a.m. Nov. 2, 2017

    - Tomi Kilgore

  15. U.S. Cheese Prices Fall

    1:32 a.m. June 25, 2016

    - Barron's Online

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/epzm

Other News on EPZM

  1. Why Is Epizyme (EPZM) Up 0.6% Since Last Earnings Report?

    11:31 a.m. Sept. 3, 2020

    - Zacks.com

  2. Epizyme's (EPZM) Q2 Earnings and Revenues Miss Estimates

    11:29 a.m. Aug. 5, 2020

    - Zacks.com

  3. 10-Q: EPIZYME, INC.

    7:07 a.m. Aug. 4, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. Epizyme A Buy For Tazverik And Epigenetic Platform

    1:37 a.m. July 1, 2020

    - Seeking Alpha

  5. Stocks To Watch: Spotlight On EVs, Shipping And Hertz

    8:55 a.m. June 13, 2020

    - Seeking Alpha

  6. Epizyme, Inc. 2020 Q1 - Results - Earnings Call Presentation

    10:53 a.m. May 4, 2020

    - Seeking Alpha

  7. Loading more headlines...
/news/pressrelease/company/us/epzm

Press Releases on EPZM

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.